PLAR Implant and Delivery System
Pre-clinical- Indications
- Mitral valve regurgitation
Company intelligence / Profile preview
Polares Medical
Palo Alto, California, United Statespolaresmedical.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Polares Medical is developing a unique trans-catheter mitral valve hemi-replacement device for treating mitral regurgitation. The company has completed preclinical development and entered pilot clinical studies as of 2020 after raising significant financing rounds ($25M in 2018 and $40M in 2020). No published pivotal or commercial-stage results are available yet.
- Therapeutic areas
- Cardiovascular
- Modalities
- DeviceNon-pharmacological therapy
- Industry
- Implantable Medical Devices
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Polares Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Polares Medical.